Apigenin 7-glucoside reprograms tumor metabolism and enhances immunotherapy efficacy in colorectal cancer via DLX5.
Saved in:
| Title: | Apigenin 7-glucoside reprograms tumor metabolism and enhances immunotherapy efficacy in colorectal cancer via DLX5. |
|---|---|
| Authors: | Zou G; Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China., Jiang Y; Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China.; Department of General Surgery, School of Medicine, South China University of Technology, Guangzhou, 511442, China., Ma R; Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China., Li S; Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. lisongyan301@163.com., Zhang C; Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, China. zcjdlyxzx@163.com. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Feb 25. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1699-3055 |
|---|---|
| DOI: | 10.1007/s12094-026-04286-9 |
